PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Su, Dan ^a,b   Xu, Haiyan ^b   Feng, Jianguo ^b   Gao, Yun ^b   Gu, Linhui ^b   Ying, Lisha ^b   Katsaros, Dionyssios ^c   Yu, Herbert ^d   Xu, Shenhua ^b   Qi, Ming ^a,e  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

^c UNIVERSITY OF TURIN   (Italy)

^d YALE CANCER CENTER   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; PROGRAMMED DEATH 6 PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; PDCD6 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CELL CYCLE; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; OVARY CANCER; OVERALL SURVIVAL; PREDICTION; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TUMOR VOLUME; WESTERN BLOTTING; CANCER INVASION; CELL PROLIFERATION; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; KAPLAN MEIER METHOD; LENTIVIRINAE; METABOLISM; METASTASIS; MIDDLE AGED; NEOPLASM; NONPARAMETRIC TEST; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GENETIC VECTORS; HUMANS; KAPLAN-MEIER ESTIMATE; LENTIVIRUS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RNA, MESSENGER; RNA, SMALL INTERFERING; STATISTICS, NONPARAMETRIC; TRANSFECTION;

EID: 84857410686     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-31     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer Statistics, 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
2. du Bois A, Luck HJ, Meier W, Mobus V, Costa S, Richter B, Bauknecht T, Warm M, Schroeder W, Olbricht S. Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynakologische Onkologie. Semin Oncol 1997, 24:28-S11.
3. Aravantinos G, Fountzilas G, Kosmidis P, Dimopoulos MA, Stathopoulos GP, Pavlidis N, Bafaloukos D, Papadimitriou C, Karpathios S, Georgoulias V. Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study. Ann Oncol 2005, 16:1116-1122. 10.1093/annonc/mdi223, 15928071.
4. Shenhua X, Hanzhou M, Lijuan Q, Yongzhen S, Chihong Z, Xiaoshu H, Yongliang G, Shanzing D. Establishment and Characterization of a Model of Highly Metastasizing Human Ovarian Cancer Transplanted into Subcutis of the Nude Mice. J Exp Clin Cancer Res 1995, 14:387-394.
5. Shenhua X, Lijuan Q, Hanzhou N, Xinghao N, Chihong Z, Gu Z, Weifang D, Yongliang G. Establishment of a highly metastatic human ovarian cancer cell line (HO-8910 PM) and its characterization. J Exp Clin Cancer Res 1999, 18:233-239.
6. Su D, Xu SH, Gu LH. Comparative proteomics analysis of differentially expressed metastasis-associated proteins in human ovarian cancer cell lines. Zhonghua Fu Chan Ke Za Zhi 2005, 40:619-622.
7. Jung YS, Kim KS, Dong Kim K, Lim JS, Kim JW, Kim E. Apoptosis-Linked Gene 2 Binds to the Death Domain of Fas and Dissociates from Fas during Fas-Mediated Apoptosis in Jurkat Cells. Biochem Biophys Res Commun 2001, 288:420-426. 10.1006/bbrc.2001.5769, 11606059.
8. Shibata H, Yamada K, Mizuno T, Yorikawa C, Takahashi H, Satoh H, Kitaura Y, Maki M. The Penta-EF-Hand Protein ALG-2 Interacts with a Region Containing PxY Repeats in Alix/AIP1, Which Is Required for the Subcellular Punctate Distribution of the Amino-Terminal Truncation Form of Alix/AIP1. J Biochem 2004, 135:117. 10.1093/jb/mvh014, 14999017.
9. Jang IK, Hu R, Lacana E, D'Adamio L, Gu H. Apoptosis-Linked Gene 2-Deficient Mice Exhibit Normal T-Cell Development and Function. Mol Cell Biol 2002, 22:4094-4100. 10.1128/MCB.22.12.4094-4100.2002, 133871, 12024023.
10. la Cour JM, Mollerup J, Winding P, Tarabykina S, Sehested M, Berchtold MW. Up-Regulation of ALG-2 in Hepatomas and Lung Cancer Tissue. Am J Pathol 2003, 163:81-89. 10.1016/S0002-9440(10)63632-2, 1868153, 12819013.
11. Shepherd JH. Revised FIGO staging for gynaecological cancer. BJOG: An Int J Obstetrics Gynaecology 1989, 96:889-892.
12. Scully RE, Sobin LH. Histologic typing of ovarian tumors. Arch Pathol Lab Med 1987, 111:794-795.
13. Vito P, Lacana E, D'Adamio L. Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 1996, 271:521-525. 10.1126/science.271.5248.521, 8560270.
14. Maki M, Narayana SV, Hitomi K. A growing family of the Ca2 + -binding proteins with five EF-hand motifs. Biochem J 1997, 328(Pt 2):718-720. 1218977, 9441591.
15. Maki M, Yamaguchi K, Kitaura Y, Satoh H, Hitomi K. Calcium-induced exposure of a hydrophobic surface of mouse ALG-2, which is a member of the penta-EF-hand protein family. J Biochem 1998, 124:1170-1177.
16. Suzuki H, Kawasaki M, Inuzuka T, Okumura M, Kakiuchi T, Shibata H, Wakatsuki S, Maki M. The mechanism of Ca2 + -dependent recognition of Alix by ALG-2: insights from X-ray crystal structures. Biochem Soc Trans 2009, 37:190-194. 10.1042/BST0370190, 19143629.
17. Satoh H, Nakano Y, Shibata H, Maki M. The penta-EF-hand domain of ALG-2 interacts with amino-terminal domains of both annexin VII and annexin XI in a Ca2 + -dependent manner. Biochim Biophys Acta 2002, 1600:61-67.
18. Shibata H, Suzuki H, Yoshida H, Maki M. ALG-2 directly binds Sec31A and localizes at endoplasmic reticulum exit sites in a Ca2 + -dependent manner. Biochem Biophys Res Commun 2007, 353:756-763. 10.1016/j.bbrc.2006.12.101, 17196169.
19. D'Adamio L, Lacana E, Vito P. Functional cloning of genes involved in T-cell receptor-induced programmed cell death. Semin Immunol 1997, 9:17-23. 10.1006/smim.1996.0057, 9106304.
20. Mahul-Mellier AL, Strappazzon F, Petiot A, Chatellard-Causse C, Torch S, Blot B, Freeman K, Kuhn L, Garin J, Verna JM. Alix and ALG-2 Are Involved in Tumor Necrosis Factor Receptor 1-induced Cell Death. J Biol Chem 2008, 283:34954. 10.1074/jbc.M803140200, 3259881, 18936101.
21. Jang IK, Hu R, Lacana E, D'Adamio L, Gu H. Apoptosis-linked gene 2-deficient mice exhibit normal T-cell development and function. Mol Cell Biol 2002, 22:4094-4100. 10.1128/MCB.22.12.4094-4100.2002, 133871, 12024023.
22. la Cour JM, Mollerup J, Winding P, Tarabykina S, Sehested M, Berchtold MW. Up-regulation of ALG-2 in hepatomas and lung cancer tissue. Am J Pathol 2003, 163:81-89. 10.1016/S0002-9440(10)63632-2, 1868153, 12819013.
23. Aviel-Ronen S, Coe BP, Lau SK. da Cunha Santos G, Zhu CQ, Strumpf D, Jurisica I, Lam WL, Tsao MS: Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features. Proc Natl Acad Sci USA 2008, 105:10155-10160. 10.1073/pnas.0709618105, 2465804, 18632575.
24. la Cour JM, Hj BR, Mollerup J, Simon R, Sauter G, Berchtold MW. The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability. Molecular Oncology 2008, 1:431-439. 10.1016/j.molonc.2007.08.002, 19383317.
25. Hoj BR, la Cour JM, Mollerup J, Berchtold MW. ALG-2 knockdown in HeLa cells results in G2/M cell cycle phase accumulation and cell death. Biochem Biophys Res Commun 2009, 378:145-148. 10.1016/j.bbrc.2008.11.021, 19013425.
26. la Cour JM, Hoj BR, Mollerup J, Simon R, Sauter G, Berchtold MW. The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability. Mol Oncol 2008, 1:431-439. 10.1016/j.molonc.2007.08.002, 19383317.
27. Rho SB, Song YJ, Lim MC, Lee SH, Kim BR, Park SY. Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2. Cell Signal 2012, 24:131-139. 10.1016/j.cellsig.2011.08.013, 21893193.